Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11087 |
DOV-216,303 Free Base
DOV-216303 |
Dopamine Receptor; Serotonin Transporter; Norepinephrine | GPCR/G Protein; Neuroscience |
DOV-216,303 Free Base (DOV-216303) 是血清素、去甲肾上腺素和多巴胺再摄取的抑制剂,IC50 为 14、20 和 78 nM。 DOV-216,303 Free Base 具有抗抑郁作用。 | |||
T69275 |
DOV-102677
|
||
DOV-102677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a triple reuptake inhibitor, or serotonin-norepinephrine-dopamine reuptake inhibitor. It is the-enantiomer of DOV-216,303, and its-enantiomer is DOV-21,947. |